COVID-driven drop in cancer screenings didn't result in more new cases
Dr. Julie Brahmer (R) and Katie Thornton review PET scans of a patient being treated at the Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore. Photo: Win McNamee/Getty Images
The dropoff in cancer screenings during the pandemic didn't result in significantly more breast, cervical and colon cancer cases, or how advanced those cases were, according to a review of nearly 375,000 diagnoses in electronic health records.
Why it matters: The findings from Epic Research could ease concerns about countless hidden cases and more advanced stages of disease stemming from millions of missed screenings during the height of the pandemic.
- Previous research showed the decline in primary care visits and routine tests early in the pandemic resulted in 94% decreases in both breast cancer and cervical cancer screenings and an 86% decrease in colon cancer screenings before rebounding somewhat in 2021.
What they found: There was a clear drop in cancer cases early in the pandemic that accompanied the decrease in screening. However, as screening rates returned to normal, cancer detection rates did, too.
- There wasn't a significant increase in the rate of cancer diagnoses in 2020-2022 compared to pre-pandemic, and new diagnoses of advanced cancers also didn’t rise.
Yes, but: It could take years to fully assess the impact of missed screenings, especially for cancers with longer intervals between screenings.
Source: Read Full Article